Two Sigma Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-335,594
Closed -$40.6M 3416
2023
Q1
$40.6M Buy
335,594
+208,105
+163% +$23.9M 0.12% 215
2022
Q4
$14.6M Buy
+127,489
New +$14.1M 0.05% 433

Other funds holding BSX.PRA

Two Sigma Investments's BSX.PRA Position: Q2 2023 in Review

Two Sigma Investments sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 335,594 shares — an estimated $40.6M sold.

Two Sigma Investments first reported a position in BSX.PRA in Q4 2022 and held it in 2 quarters. The position peaked at $40.6M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • Two Sigma Investments reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 335,594 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $40.6M.
  • Two Sigma Investments first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2022 and held it in 2 quarters.
  • Two Sigma Investments's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $40.6M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.